MENU
ABUS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arbutus Biopharma (ABUS) Earnings Date & Reports

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ABUS is expected to report earnings to fall 72.31% to -3 cents per share on July 31

Arbutus Biopharma ABUS Stock Earnings Reports
Q2'25
Est.
$-0.04
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.01
The last earnings report on May 14 showed earnings per share of -12 cents, missing the estimate of -10 cents. With 685.82K shares outstanding, the current market capitalization sits at 652.15M.
View a ticker or compare two or three
ABUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of drugs to improve the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
701 Veterans Circle
Phone
+1 267 469-0914
Employees
73
Web
http://www.arbutusbio.com